US 12012419
Heterocyclic compound
granted A61KA61K31/5365A61P
Quick answer
US patent 12012419 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/5365, A61P, A61P1/00, A61P43/00